Department of Defense

Latest Headlines

Latest Headlines

DOD selects Bavarian Nordic to develop vaccine against biological threats

The Department of Defense has selected Denmark's Bavarian Nordic to develop a vaccine against two potential biological pathogens deemed to be threats to national security.

DoD ponies up $15M to develop Terumo's blood-cleaning tech

Terumo BCT, the blood-focused division of the Japanese med tech giant, has signed a deal with the U.S. Department of Defense to share costs in the development of a device that can treat donated blood used in emergency transfusions.

Combat Medical Systems gains $86M govt. contract

Founded just 5 years ago, Combat Medical Systems nailed down an $86 million U.S. Department of Defense contract to provide a slew of medical equipment and devices for military and federal agencies over the next 5 years.

Sarepta reports promising preclinical results for antibioterrorism drug

Sarepta Therapeutics is getting closer to developing a therapy to treat a rare animal-borne disease considered a bioterrorism threat by the Centers for Disease Control and Prevention.

General Dynamics lands a $42M DoD drug development contract

The big defense contractor General Dynamics is hiring a team to help it execute on a $41.8 million contract to develop new drugs, devices and vaccines for the military.

Video game players take on deadly sepsis for U.S. military

A unit of the U.S. Department of Defense has challenged the Foldit video gamers to craft proteins in a virtual online setting that bind to pathogens in the blood, to bolster research of sepsis treatments.

Luminex scores $11.6M deal for biothreat Dx

Luminex has signed an $11.5 million deal with the Department of Defense, tasked with developing a hand-held diagnostics tool that can detect biothreat agents.

SRI gets Defense grant to develop oral-delivered MS drug

The Department of Defense has awarded a one-year grant to SRI International's bioscience division to develop an orally administered multiple sclerosis drug.

DOD-funded project fuels inner ear drug delivery

Tinnitus is the most common disability for American vets, and new technology could allow doctors to treat the condition.

DoD gives NeoStem $1.7M to develop adult stem cells for osteoporosis

NeoStem, a New York-based biopharmaceutical company, has been awarded almost $1.8 million from the U.S. Department of Defense to develop the company's Very Small Embryonic-Like (VSEL) stem cell